Galmed Pharmaceuticals Ltd. (EOCN): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2025)
- $6.9M
- Total Assets (FY2025)
- $18.6M
- Total Equity (FY2025)
- $15.8M
- Cash Flows from Operating Activities (FY2025)
- -$6.3M
Source: Galmed Pharmaceuticals Ltd. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
